Literature DB >> 21883415

The in vitro effects of antibiotics on cell viability and gene expression of equine bone marrow-derived mesenchymal stromal cells.

R A Parker1, P D Clegg, S E Taylor.   

Abstract

OBJECTIVES: To investigate the effects of commonly used antibiotics on cell viability and gene expression of equine bone marrow-derived mesenchymal stromal cells (MSC) in vitro.
MATERIALS AND METHODS: Bone marrow-derived MSC were cultured in media containing gentamicin, amikacin, penicillin, enrofloxacin or ceftiofur at concentrations of 50, 100, 200 and 500 µg/ml. The alamarBlue fluorescence assay was used to assess cell viability over 48 h. After 5 days the cells were released and lysed prior to RNA extraction and reverse transcription. RNA levels were assessed using spectrophotometry and quantitative PCR was used to analyse gene expression of COL1A2, COL5A1, TNC, TNFα, CASP3, BCl2 and TGFβR2 relative to the reference gene GAPDH.
RESULTS: Enrofloxacin produced a significant concentration-dependent reduction in cell viability at 200 µg/ml and higher concentrations (P = 0.009). Amikacin significantly reduced cell viability at 500 µg/ml (P = 0.002). Penicillin had no effect on cell viability at the concentrations tested (P = 0.18). Gentamicin and ceftiofur showed some interaction with the assay but had no overall effect on cell viability. At 500 µg/ml gentamicin (P<0.001), amikacin (P = 0.03), enrofloxacin (P<0.001) and ceftiofur (P<0.001) caused significant reductions in RNA levels. At 50 µg/ml gentamicin (P<0.001) and amikacin (P = 0.019) reduced BCl2 expression. Enrofloxacin produced a significant increase in COL1A2 expression (P<0.001).
CONCLUSIONS: Enrofloxacin reduced MSC viability in vitro and may require cautious use in clinical situations. Penicillin has minimal detrimental effects on MSC in vitro and its use in conjunction with MSC at implantation appears safe. Further work is needed to fully investigate the effects of gentamicin, amikacin and ceftiofur. POTENTIAL RELEVANCE: Clinicians using local antibiotic administration should consider the potential for local toxicity as well as the need for effective concentrations of the antibiotic.
© 2011 EVJ Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21883415     DOI: 10.1111/j.2042-3306.2011.00437.x

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  8 in total

1.  Osteogenic potential of sorted equine mesenchymal stem cell subpopulations.

Authors:  Catherine L Radtke; Rodolfo Nino-Fong; Juan Carlos Rodriguez-Lecompte; Blanca P Esparza Gonzalez; Henrik Stryhn; Laurie A McDuffee
Journal:  Can J Vet Res       Date:  2015-04       Impact factor: 1.310

2.  Effect of Antibiotic Class on Stroke Outcome.

Authors:  Dannielle Zierath; Allison Kunze; Leia Fecteau; Kyra Becker
Journal:  Stroke       Date:  2015-07-02       Impact factor: 7.914

3.  Pathways involved in pony body size development.

Authors:  Jun Fang; Dong Zhang; Jun Wei Cao; Li Zhang; Chun Xia Liu; Yan Ping Xing; Feng Wang; Hong Yang Xu; Shi Chao Wang; Yu Ling; Wei Wang; Yan Ru Zhang; Huan Min Zhou
Journal:  BMC Genomics       Date:  2021-01-18       Impact factor: 3.969

4.  Use of in vitro assays to identify antibiotics that are cytotoxic to normal equine chondrocytes and synovial cells.

Authors:  Lynn Pezzanite; Lyndah Chow; Gabriella Piquini; Gregg Griffenhagen; Dominique Ramirez; Steven Dow; Laurie Goodrich
Journal:  Equine Vet J       Date:  2020-07-03       Impact factor: 2.888

Review 5.  Quaternized chitosan as an antimicrobial agent: antimicrobial activity, mechanism of action and biomedical applications in orthopedics.

Authors:  Honglue Tan; Rui Ma; Chucheng Lin; Ziwei Liu; Tingting Tang
Journal:  Int J Mol Sci       Date:  2013-01-16       Impact factor: 5.923

6.  Isolation of equine multipotent mesenchymal stromal cells by enzymatic tissue digestion or explant technique: comparison of cellular properties.

Authors:  Claudia Gittel; Walter Brehm; Janina Burk; Henriette Juelke; Carsten Staszyk; Iris Ribitsch
Journal:  BMC Vet Res       Date:  2013-10-29       Impact factor: 2.741

Review 7.  Cell-Based Therapies for Joint Disease in Veterinary Medicine: What We Have Learned and What We Need to Know.

Authors:  Sophie Helen Bogers
Journal:  Front Vet Sci       Date:  2018-04-16

8.  A Survey of Clinical Usage of Non-steroidal Intra-Articular Therapeutics by Equine Practitioners.

Authors:  Ana Velloso Alvarez; Lindsey H Boone; Amy Poulin Braim; Jenifer S Taintor; Fred Caldwell; James C Wright; Anne A Wooldridge
Journal:  Front Vet Sci       Date:  2020-10-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.